Cyclophosphamide (Avera McKennan Hospital)


Welcome to the PulseAid listing for the Cyclophosphamide drug offered from Avera McKennan Hospital. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Avera McKennan Hospital
NON-PROPRIETARY NAME: Cyclophosphamide
SUBSTANCE NAME: CYCLOPHOSPHAMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Alkylating Activity [MoA],Alkylating Drug [EPC]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-04-23
END MARKETING DATE: 0000-00-00


Cyclophosphamide HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCyclophosphamide from Avera McKennan Hospital
LABELER NAME: Avera McKennan Hospital
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/1)
START MARKETING DATE: 2015-04-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69189-0383_148d21b9-fe9e-4c7f-8eb1-537f7e68d416
PRODUCT NDC: 69189-0383
APPLICATION NUMBER: NDA203856

Other CYCLOPHOSPHAMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalCyclophosphamide
Baxter Healthcare CorporationCYCLOPHOSPHAMIDE
Physicians Total Care, Inc.Cyclophosphamide
Sandoz Inc.Cyclophosphamide
West-Ward Pharmaceuticals Corp.Cyclophosphamide